BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24122662)

  • 21. Triple simultaneous primary invasive gynecological malignancies: a case report.
    Takatori E; Shoji T; Miura Y; Takeuchi S; Uesugi N; Sugiyama T
    J Obstet Gynaecol Res; 2014 Feb; 40(2):627-31. PubMed ID: 24147606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy in elderly patients with gynecological cancer.
    Palaia I; Loprete E; Musella A; Marchetti C; Di Donato V; Bellati F; Benedetti Panici P
    Oncology; 2013; 85(3):168-72. PubMed ID: 24008766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Int J Mol Med; 2008 May; 21(5):637-43. PubMed ID: 18425357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gynecologic malignancies.
    Schaebler DL; Schilder RJ; Young RC
    Cancer Chemother Biol Response Modif; 1994; 15():555-80. PubMed ID: 7779599
    [No Abstract]   [Full Text] [Related]  

  • 25. CBHA is a family of hybrid polar compounds that inhibit histone deacetylase, and induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Matsuda K; Kusumoto M; Narahara H
    Oncology; 2006; 70(2):97-105. PubMed ID: 16601366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laparoscopy in gynecologic malignancies.
    Chi DS
    Oncology (Williston Park); 1999 Jun; 13(6):773-82; discussion 782-5 passim. PubMed ID: 10378217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear localisation of glutathione S-transferase pi is an evaluation factor for drug resistance in gynaecological cancers.
    Soh Y; Goto S; Kitajima M; Moriyama S; Kotera K; Nakayama T; Nakajima H; Kondo T; Ishimaru T
    Clin Oncol (R Coll Radiol); 2005 Jun; 17(4):264-70. PubMed ID: 15997922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffusely infiltrating endometrial carcinomas with no stromal response: report of a series, including cases with cervical and ovarian involvement and emphasis on the potential for misdiagnosis.
    Kalyanasundaram K; Ganesan R; Perunovic B; McCluggage WG
    Int J Surg Pathol; 2010 Apr; 18(2):138-43. PubMed ID: 19117974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gynecologic malignancies in older women.
    Mirhashemi R; Nieves-Neira W; Averette HE
    Oncology (Williston Park); 2001 May; 15(5):580-6; discussion 592-4, 597-8. PubMed ID: 11396354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The place of para-aortic lymphadenectomy in gynaecological malignancies. An old debate].
    Philippe AC; Dauplat J; Martinez A; Canis M; Bourdel N; Ferron G; Pomel C
    Bull Cancer; 2014 Apr; 101(4):345-8. PubMed ID: 24793624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymph node metastasis in a gynecologic malignancy.
    Kamura T; Jeon JD
    Yonsei Med J; 2002 Dec; 43(6):783-91. PubMed ID: 12497663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laparoscopic lymphadenectomy.
    Melendez TD; Childers JM
    Curr Opin Obstet Gynecol; 1995 Aug; 7(4):307-10. PubMed ID: 7578972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Trends in surgery of gynecologic cancers].
    Pfleiderer A
    Geburtshilfe Frauenheilkd; 1991 Oct; 51(10):847-9. PubMed ID: 1761175
    [No Abstract]   [Full Text] [Related]  

  • 34. Wnt Signaling in Gynecologic Malignancies.
    McMellen A; Woodruff ER; Corr BR; Bitler BG; Moroney MR
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
    Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
    Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surface antigen expression on peripheral blood monocytes in women with gynecologic malignancies.
    Jóźwik M; Okungbowa OE; Lipska A; Jóźwik M; Smoktunowicz M; Semczuk A; Jóźwik M; Radziwon P
    BMC Cancer; 2015 Mar; 15():129. PubMed ID: 25880896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gynecologic cancer in the elderly.
    Termrungruanglert W; Kudelka AP; Edwards CL; Delclos L; Verschraegen CF; Kavanagh JJ
    Clin Geriatr Med; 1997 May; 13(2):363-79. PubMed ID: 9115456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The contrast between chemotherapy via pelvic retroperitoneal cannulation and intraperitoneal chemotherapy in gynecological malignancies cancers with lymph node metastases].
    Cao Z; Zhang D; Peng Z
    Zhonghua Fu Chan Ke Za Zhi; 1999 Sep; 34(9):540-3. PubMed ID: 11360639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The application of operative laparoscopy to gynecologic oncology.
    Jennings TS; Dottino PR
    Curr Opin Obstet Gynecol; 1994 Feb; 6(1):80-5. PubMed ID: 8180356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rationale and clinical experience with epidermal growth factor receptor inhibitors in gynecologic malignancies.
    Vaidya AP; Parnes AD; Seiden MV
    Curr Treat Options Oncol; 2005 Mar; 6(2):103-14. PubMed ID: 15717992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.